|
Blättern nach Exzellenzfelder
Anzahl der Einträge auf dieser Ebene: 5. 2024
Zehentmayr, Franz, Feurstein, Petra, Ruznic, Elvis, Langer, Brigitte, Grambozov, Brane, Klebermass, Marisa, Hüpfel, Herbert, Feichtinger, Johann, Minasch, Danijela, Heilmann, Martin, Breitfelder, Barbara, Steffal, Claudia, Gastinger-Grass, Gisela, Kirchhammer, Karoline, Kazil, Margit, Stranzl, Heidi und Dieckmann, Karin
(2024)
Durvalumab impacts progression-free survival while high-dose radiation >66 Gy improves local control without excess toxicity in unresectable NSCLC stage III: Real-world data from the Austrian radio-oncological lung cancer study association registry (ALLSTAR).
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 196.
p. 110294.
ISSN 1879-0887
|
![Feichtinger Durvalumab impacts progression free survival while high-dose radiation 66 Gy improves local control without excess toxicity in unresectable NSCLC stage III Elsevier 2024.pdf [thumbnail of Feichtinger Durvalumab impacts progression free survival while high-dose radiation 66 Gy improves local control without excess toxicity in unresectable NSCLC stage III Elsevier 2024.pdf]](https://eprints.vinzenzgruppe.at/10574/1.hassmallThumbnailVersion/Feichtinger%20Durvalumab%20impacts%20progression%20free%20survival%20while%20high-dose%20radiation%2066%20Gy%20improves%20local%20control%20without%20excess%20toxicity%20in%20unresectable%20NSCLC%20stage%20III%20Elsevier%202024.pdf)  Vorschau
|
Haderlein, Marlen, von der Grün, Jens, Balermpas, Panagiotis, Rödel, Claus, Hautmann, Matthias G, Steger, Felix, Bohr, Christopher, Hehr, Thomas, Stromberger, Carmen, Budach, Volker, Schymalla, Markus, Engenhart-Cabillic, Rita, Kocik, Lukas, Geinitz, Hans, Nestle, Ursula, Klautke, Gunter, Scherl, Claudia, Gall, Christine, Frey, Benjamin, Schubert, Philipp, Semrau, Sabine, Ott, Oliver, Kesting, Marco, Iro, Heinrich, Mueller, Sarina K und Fietkau, Rainer
(2024)
De-intensification of postoperative radiotherapy in head and neck cancer irrespective of human papillomavirus status-results of a prospective multicenter phase II trial (DIREKHT Trial).
Frontiers in oncology, 14.
p. 1447123.
ISSN 2234-943X
|
![Haderlein DIREKHT Studie Front Oncol 2024.pdf [thumbnail of Haderlein DIREKHT Studie Front Oncol 2024.pdf]](https://eprints.vinzenzgruppe.at/10575/1.hassmallThumbnailVersion/Haderlein%20DIREKHT%20Studie%20Front%20Oncol%202024.pdf)  Vorschau
|
Pichler, Josef, Traub-Weidinger, Tatjana, Spiegl, Kurt, Imamovic, Larisa, Braat, Arthur J A T, Snijders, Tom J, Verhoeff, Joost J C, Flamen, Patrick, Tauchmanova, Libuse, Hayward, Colin und Kluge, Andreas
(2024)
Results from a phase I study of 4-<i>l</i>-[131I]iodo-phenylalanine ([<sup>131</sup>I]IPA) with external radiation therapy in patients with recurrent glioblastoma (IPAX-1).
Neuro-oncology advances, 6 (1).
vdae130.
ISSN 2632-2498
|
![Pichler Results from a phase I study IPAX-1 Neurooncol Advanc 2024.pdf [thumbnail of Pichler Results from a phase I study IPAX-1 Neurooncol Advanc 2024.pdf]](https://eprints.vinzenzgruppe.at/10576/1.hassmallThumbnailVersion/Pichler%20Results%20from%20a%20phase%20I%20study%20IPAX-1%20Neurooncol%20Advanc%202024.pdf)  Vorschau
|
Diese Liste wurde am Sat Feb 22 03:03:07 2025 UTC generiert.
|
|